HALOZYME THERAPEUTICS, INC. - COM (HALO)

Q3 2017 13F Holders as of 9/30/2017

Type / Class
Equity / COM
Number of holders
165
Total Shares
121M
Shares change
-371K
Total reported value, excl. options
$2.11B
Value change
-$3.89M
Put/Call ratio
0.12
Number of buys
79
Number of sells
-66
Price
$17.37
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.